Stevia rebaudiana Bertoni Leaves Extract as a Nutraceutical with Hypoglycemic Activity in Diabetic Rats

Keri Lestari, Abdurahman Ridho, Nuning Nurcayani, Zelika Mega Ramadhania, Melisa Intan Barliana

Abstract


BACKGROUND: The prevalence of diabetes mellitus is growing every year, including in Indonesia. Medicinal herbs were used empirically for lowering blood glucose. One of potential herb to have hypoglycemic activity is Stevia rebaudiana Bertoni. S. rebaudiana Bertoni leaves contain stevoside, a natural, lowcalorie sweetener that is 300 times sweeter than saccharose. In this study, we aimed to explore the hypoglycemic activity of S. rebaudiana Bertoni leaves extract in a rat model of type 2 diabetes mellitus (T2DM).

METHODS: Male Wistar rats were feed high-fat, highcarbohydrate feed and sugar solution for 74 days to induce a diabetic rat model. The animals were then divided into five groups consisting of a negative control group treated with 2% Pulvis Gom Arabicum; a positive control group treated with Metformin 45 mg/kg body weight; and three test groups treated with aqueous extract of S. rebaudiana Bertoni leaves at doses of 3.125, 6.25 and 12.5 mg/kg BW for 36 days. Blood glucose was measured on days 14, 28 and 36.

RESULTS: The results showed that blood glucose levels over 36 days were significantly (p=0.043) lower in the group treated with S. rebaudiana Bertoni leaves extract. Further Newman-Keuls analysis suggested that the hypoglycemic activity of S. rebaudiana Bertoni leaves extract was dosedependent.

CONCLUSION: Our results indicate that S. rebaudiana Bertoni leaves extract has a potential role as a hypoglycemic agent in the treatment of T2DM.

KEYWORDS: Stevia rebaudiana Bertoni, nutraceuticals, hypoglycemic, diabetic rats


Full Text:

PDF

References


Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014; 383: 1068-83, CrossRef.

Hussain Y, Jain SK, Samaiya PK. Short-term westernized (HFFD) diet fed in adolescent rats: Effect on glucose homeostasis, hippocampal insulin signaling, apoptosis and related cognitive and recognition memory function. Behav Brain Res. 2019; 361: 113-21, CrossRef.

Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87: 4-14, CrossRef.

Goyal SK, Samsher, Goyal RK. Stevia (Stevia rebaudiana) a biosweetener: a review. Int J Food Sci Nutr. 2010; 61: 1-10, CrossRef.

Ferrazzano GF, Cantile T, Alcidi B, Coda M, Ingenito A, Zarrelli A, et al. Is Stevia rebaudiana Bertoni a non cariogenic sweetener? A review. Molecules. 2015; 21: E38, CrossRef.

Lemus-Mondaca R, Vega-Galvez A, Zura-Bravo L, Ah-Hen K. Stevia rebaudiana Bertoni, source of a high-potency natural sweetener: A comprehensive review on the biochemical, nutritional and functional aspects. Food Chem. 2012; 132: 1121-32, CrossRef.

Karim MZ, Uesugi D, Nakayama N, Hossain MM, Ishihara K, Hamada H. Identification of stevioside using tissue culture-derived stevia (Stevia rebaudiana) leaves. Biochem Insights. 2015; 8(Suppl 2): 33-7, CrossRef.

Assaei R, Mokarram P, Dastghaib S, Darbandi S, Darbandi M, Zal F, et al. Hypoglycemic effect of aquatic extract of stevia in pancreas of diabetic rats: PPARgamma-dependent regulation or antioxidant potential. Avicenna J Med Biotechnol. 2016; 8: 65-74, PMID.

Sing S, Garg V. Antidiabetic, antidyslipidymic and antioxidative potential of methanolic root extract of Stevia rebaudiana (Bertoni) on alloxan induced diabetic mice. J Pharm Pharm Sci. 2014; 3: 1859-72, article.

Bhasker S, Madhav H, Chinnamma M. Molecular evidence of insulinomimetic property exhibited by steviol and stevioside in diabetes induced L6 and 3T3L1 cells. Phytomedicine. 2015; 22: 1037-44, CrossRef.

Ceunen S, Geuns JM. Steviol glycosides: chemical diversity, metabolism, and function. J Nat Prod. 2013; 76: 1201-28, CrossRef.

Ohta M, Sasa S, Inoue A, Tamai T, Fujita I, Morita K, et al. Characterization of novel steviol glycoside from leaves of Stevia rebaudiana Morita. J Appl Glycosci. 2010; 57: 199-209, CrossRef.

Chaves G, Britez N, Oviedo G, Gonzalez G, Italiano C, Blanes M, et al. Heavy drinkers of Ilex paraguariensis beverages show lower lipid profiles but higher body weight. Phytother Res. 2018; 32: 1030-8, CrossRef.

Mayasari NR, Susetyowati, Wahyuningsih MSH, Probosuseno. Antidiabetic effect of rosella-stevia tea on prediabetic women in Yogyakarta, Indonesia. J Am Coll Nutr. 2018; 37: 373-9, CrossRef.

Ritu M, Nandini J. Nutritional composition of Stevia rebaudiana, a sweet herb, and its hypoglycaemic and hypolipidaemic effect on patients with non-insulin dependent diabetes mellitus. J Sci Food Agric. 2016; 96: 4231-4, CrossRef.

Vasilescu R. Metabolic syndrome in clinical practice considerations on diagnostic criteria and prevalence. Terapeutica. 2011; XV: 93-7, article.

Lozano I, Van der Werf R, Bietiger W, Seyfritz E, Peronet C, Pinget M, et al. High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutr Metab. 2016; 13: 15, CrossRef.

Zhuo J, Zeng Q, Cai D, Zeng X, Chen Y, Gan H, et al. Evaluation of type 2 diabetic mellitus animal models via interactions between insulin and mitogenactivated protein kinase signaling pathways induced by a high fat and sugar diet and streptozotocin. Mol Med Rep. 2018; 17: 5132-42, CrossRef.

Fatih Aydin A, Kucukgergin C, Bingul I, Dogan-Ekici I, DogruAbbasoglu S, Uysal M. Effect of carnosine on renal function, oxidation and glycation products in the kidneys of high-fat diet/streptozotocin-induced diabetic rats. Exp Clin Endocrinol Diabetes. 2017; 125: 282-9, CrossRef.

Liu XY, Liu FC, Deng CY, Zhang MZ, Yang M, Xiao DZ, et al. Left ventricular deformation associated with cardiomyocyte Ca(2+) transients delay in early stage of low-dose of STZ and high-fat diet induced type 2 diabetic rats. BMC Cardiovasc disor. 2016; 16: 41, CrossRef.

Maslov LN, Naryzhnaya NV, Boshchenko AA, Popov SV, Ivanov VV, Oeltgen PR. Is oxidative stress of adipocytes a cause or a consequence of the metabolic syndrome? J Clin Transl Endocrinol. 2019; 15: 1-5, CrossRef.

Paglialunga S, Ludzki A, Root-McCaig J, Holloway GP. In adipose tissue, increased mitochondrial emission of reactive oxygen species is important for short-term high-fat diet-induced insulin resistance in mice. Diabetologia. 2015; 58: 1071-80, CrossRef.

Odegaard AO, Jacobs DR, Jr., Sanchez OA, Goff DC, Jr., Reiner AP, Gross MD. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol. 2016; 15: 51, CrossRef.

Kobus-Moryson M, Gramza-Michalowska A. Directions on the use of stevia leaves (Stevia Rebauidana) as an additive in food products. Acta Sci Pol Technol Aliment. 2015; 14: 5-13, CrossRef.

Samuel P, Ayoob KT, Magnuson BA, Wolwer-Rieck U, Jeppesen PB, Rogers PJ, et al. Stevia leaf to stevia sweetener: exploring its science, benefits, and future potential. J Nutr. 2018; 148: 1186S-205S, CrossRef.

Carrera-Lanestosa A, Moguel-Ordonez Y, Segura-Campos M. Stevia rebaudiana Bertoni: A natural alternative for treating diseases associated with metabolic syndrome. J Med Food. 2017; 20: 933-43, CrossRef.

Piovan S, Pavanello A, Peixoto GML, Matiusso CCI, de Moraes AMP, Martins IP, et al. Stevia nonsweetener fraction displays an insulinotropic effect involving neurotransmission in pancreatic islets. Int J Endocrinol. 2018; 2018: 3189879, CrossRef.

Gupta D, Kono T, Evans-Molina C. The role of peroxisome proliferator-activated receptor gamma in pancreatic beta cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus. Diabetes Obes Metab. 2010; 12: 1036-47, CrossRef.

Atteh JO, Onagbesan OM, Tona K, Decuypere E, Geuns JM, Buyse J. Evaluation of supplementary stevia (Stevia rebaudiana, bertoni) leaves and stevioside in broiler diets: effects on feed intake, nutrient metabolism, blood parameters and growth performance. J Anim Physiol Anim Nutr. 2008; 92: 640-9, CrossRef.

Ahn YH. A journey to understand glucose homeostasis: starting from rat glucose transporter type 2 promoter cloning to hyperglycemia. Diabetes Metab J. 2018; 42: 465-71, CrossRef.




DOI: https://doi.org/10.18585/inabj.v11i2.686

Indexed by:

                 

                  

               

     

 

The Prodia Education and Research Institute